Literature DB >> 22640978

Multiple MDMA (Ecstasy) overdoses at a rave event: a case series.

Patil Armenian1, Tanya M Mamantov, Ben T Tsutaoka, Roy R L Gerona, Eric F Silman, Alan H B Wu, Kent R Olson.   

Abstract

Twelve patients with 3,4-methylenedioxymethamphetamine (MDMA) toxicity from a single rave event presented to multiple San Francisco Bay area hospitals with various life-threatening complications including seizures and hyperthermia. Eight required emergent endotracheal intubation and six had hypotension. Hyperkalemia, acute kidney injury, and rhabdomyolysis were present in most of the patients. In all, 2 patients died, 4 survived with permanent neurologic, musculoskeletal, and/or renal sequelae, and 6 survived without any apparent lasting deficits. Hyperthermia was present in 10 patients and was severe (40.9-43° C) in 7. Using multiple cooling methods, the average time to achieve cooling was 2.7 hours. Serum drug analysis was performed on 3 patients, demonstrating toxic MDMA concentrations without the presence of other xenobiotics. Two capsules confiscated by police at the event contained 82% and 98% MDMA, respectively, without other pharmacologically active compounds. Capsule #2 contained 270 mg MDMA, which is more than twice the amount of MDMA usually contained in 1 dose. The MDMA-induced hyperthermia significantly contributed to the morbidity and mortality in this case series. Factors contributing to the severity of the hyperthermia include ingestion of large doses of MDMA, a warm ambient environment, and physical exertion.

Entities:  

Keywords:  MDMA; critical care; ecstasy; hyperthermia; toxicology

Mesh:

Substances:

Year:  2012        PMID: 22640978     DOI: 10.1177/0885066612445982

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  16 in total

1.  Ecstacy-associated hyponatremia: why are women at risk?

Authors:  Michael L Moritz; Kamyar Kalantar-Zadeh; Juan Carlos Ayus
Journal:  Nephrol Dial Transplant       Date:  2013-06-26       Impact factor: 5.992

2.  Environment Influencing Serotonin Syndrome Induced by Ecstasy Abuse.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan
Journal:  Ann Forensic Res Anal       Date:  2017-03-07

3.  Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine.

Authors:  Mark J Burish; Katie L Thoren; Maura Madou; Shahed Toossi; Maulik Shah
Journal:  Neurohospitalist       Date:  2015-01

Review 4.  The hidden side of drug action: brain temperature changes induced by neuroactive drugs.

Authors:  Eugene A Kiyatkin
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

5.  Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan; H Daniel Adams; Zhiyuan Ma
Journal:  Psychopharmacology (Berl)       Date:  2014-10-11       Impact factor: 4.530

6.  MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.

Authors:  Eugene A Kiyatkin; Suelynn E Ren
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 7.  Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Authors:  Yuichi Akasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2019-12-05       Impact factor: 3.872

8.  Concerts, bars, parties, and raves: Differential risk for drug use among high school seniors according to venue attendance.

Authors:  Joseph J Palamar; Caroline Rutherford; Charles M Cleland; Katherine M Keyes
Journal:  Subst Abus       Date:  2022       Impact factor: 3.716

Review 9.  Drug checking at dance festivals: A review with recommendations to increase generalizability of findings.

Authors:  Joseph J Palamar; Nicole D Fitzgerald; Katherine M Keyes; Linda B Cottler
Journal:  Exp Clin Psychopharmacol       Date:  2021-02-18       Impact factor: 3.492

Review 10.  3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Authors:  Jerrold S Meyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.